In conclusion, our study suggests that longitudinal studies in larger sample sizes are needed to determine whether peripheral serum VEGF-A levels are appropriate markers for predicting early-onset PSD and determining the severity of depression in these patients. This evidence concerns the gene VEGFA and depressive symptom measurement.